Cargando…
A Novel Platelet-Related Gene Signature for Predicting the Prognosis of Triple-Negative Breast Cancer
Regarded as the most invasive subtype, triple-negative breast cancer (TNBC) lacks the expression of estrogen receptors (ERs), progesterone receptors (PRs), and human epidermal growth factor receptor 2 (HER2) proteins. Platelets have recently been shown to be associated with metastasis of malignant t...
Autores principales: | Xie, Jindong, Zou, Yutian, Ye, Feng, Zhao, Wanzhen, Xie, Xinhua, Ou, Xueqi, Xie, Xiaoming, Wei, Weidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790231/ https://www.ncbi.nlm.nih.gov/pubmed/35096824 http://dx.doi.org/10.3389/fcell.2021.795600 |
Ejemplares similares
-
Integrative Analysis of KCNK Genes and Establishment of a Specific Prognostic Signature for Breast Cancer
por: Zou, Yutian, et al.
Publicado: (2022) -
Establishment of a Cell Necroptosis Index to Predict Prognosis and Drug Sensitivity for Patients With Triple-Negative Breast Cancer
por: Xie, Jindong, et al.
Publicado: (2022) -
A Novel Pyroptosis-Associated Long Non-coding RNA Signature Predicts Prognosis and Tumor Immune Microenvironment of Patients With Breast Cancer
por: Ping, Liqin, et al.
Publicado: (2021) -
Applicability of Anticancer Drugs for the Triple-Negative Breast Cancer Based on Homologous Recombination Repair Deficiency
por: Liao, Gaoming, et al.
Publicado: (2022) -
Screening and diagnosis of triple negative breast cancer based on rapid metabolic fingerprinting by conductive polymer spray ionization mass spectrometry and machine learning
por: Song, Yaoyao, et al.
Publicado: (2022)